<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39429670</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2251-6093</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Iranian journal of public health</Title><ISOAbbreviation>Iran J Public Health</ISOAbbreviation></Journal><ArticleTitle>Outcomes of STEMI Patients in COVID-19 Pandemic: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1964</StartPage><EndPage>1975</EndPage><MedlinePgn>1964-1975</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18502/ijph.v53i9.16451</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The global SARS-CoV-2 pandemic has disrupted health systems and put a huge strain on hospitals and healthcare workers. Prioritizing COVID-19 patients in hospitals caused irreversible harm to cardiac patients. Although multiple studies have shown that ST-segment elevation myocardial infarction (STEMI) patients have worse admission circumstances than before the pandemic, the hospital outcomes of these patients have remained limited. This systematic review and meta-analysis examined STEMI patient outcomes during the COVID-19 epidemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted systematic searches of MEDLINE (through PubMed), Web of Science, Scopus, and Embase through Jan 10, 2021. All studies with reporting in-hospital mortality, length of stay, and door-to-balloon time with over twenty participants were included. Articles without clear definitions or results were excluded. The study followed PRISMA guidelines. The outcomes of interest were door-to-balloon time, death, and hospital stay during COVID-19 pandemic compared prior.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our meta-analysis included 12 studies and 21170 people (115-6609). The pooled analysis showed significantly more pandemic mortality (OR=1.24; 95% CI: 1.07-1.43). Ten studies (13,091) recorded door-to-balloon times. Door-to-balloon time (in minutes) significantly increased during the pandemic (Standardized Mean Difference [SMD]= 0.46; 95% CI: 0.03-0.89). The length of hospital stay was reported by five studies (n=9448). Length of hospital stay (in days) was not significantly longer during the pandemic than before the outbreak (SMD= 0.04; 95% CI: -0.19-0.26).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The COVID-19 pandemic is associated with increased mortality and door-to-balloon delay that might be attributable to the strict infection control measures in outbreak. Studies with a longer follow-up time are needed to investigate the outcomes of STEMI patients.</AbstractText><CopyrightInformation>Copyright© 2024 Khaleghparast et al. Published by Tehran University of Medical Sciences.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khaleghparast</LastName><ForeName>Shiva</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Nursing Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maleki</LastName><ForeName>Majid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noohi</LastName><ForeName>Fereidoun</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fathollahi</LastName><ForeName>Mahmood Sheikh</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalili</LastName><ForeName>Yasaman</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasebani</LastName><ForeName>Yeganeh</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rafiee</LastName><ForeName>Farnaz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrokhzadeh</LastName><ForeName>Fahimeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biglari</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Maastricht University Medical Center MUMC+, Department of Clinical Genetics, Maastricht, The Nederland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazloomzadeh</LastName><ForeName>Saeideh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Nursing Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Iran J Public Health</MedlineTA><NlmUniqueID>7505531</NlmUniqueID><ISSNLinking>2251-6085</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Door to balloon</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">ST elevation myocardial infarction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39429670</ArticleId><ArticleId IdType="pmc">PMC11490332</ArticleId><ArticleId IdType="doi">10.18502/ijph.v53i9.16451</ArticleId><ArticleId IdType="pii">IJPH-53-1964</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berger WR, Baggen V, Vorselaars VMM, et al. (2020). Dutch cardiology residents and the COVID-19 pandemic: Every little thing counts in a crisis. Neth Heart J, 28 (12):625–627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7607893</ArticleId><ArticleId IdType="pubmed">33141397</ArticleId></ArticleIdList></Reference><Reference><Citation>Giudici R, Lancioni A, Gay H, Bassi G, Chiara O. (2021). Impact of the COVID-19 outbreak on severe trauma trends and healthcare system reassessment in Lombardia, Italy: an analysis from the regional trauma registry. World J Emerg Surg, 16 (1):39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287111</ArticleId><ArticleId IdType="pubmed">34281575</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangcharoensathien V, Bassett MT, Meng Q, Mills A. (2021). Are overwhelmed health systems an inevitable consequence of covid-19? Experiences from China, Thailand, and New York State. BMJ, 372:n83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8896039</ArticleId><ArticleId IdType="pubmed">33483336</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss P, Carcel C, Hockham C, Peters SAE. (2021). The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review. Eur Heart J Qual Care Clin Outcomes, 7 (1):18–27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665454</ArticleId><ArticleId IdType="pubmed">33151274</ArticleId></ArticleIdList></Reference><Reference><Citation>Guha S, Karak A, Choudhury B, Yadav G, Yadav R. (2020). COVID 19 pandemic: Its impact on cardiovascular training and care. Indian Heart J, 72 (6):473–476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7772603</ArticleId><ArticleId IdType="pubmed">33357633</ArticleId></ArticleIdList></Reference><Reference><Citation>Burger AL, Kaufmann CC, Jäger B, et al. (2021). Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic. Wien Klin Wochenschr, 133 (23–24):1289–1297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8527966</ArticleId><ArticleId IdType="pubmed">34671829</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippo O, D’Ascenzo F, Angelini F, et al. (2020). Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy. N Engl J Med, 383 (1):88–89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224608</ArticleId><ArticleId IdType="pubmed">32343497</ArticleId></ArticleIdList></Reference><Reference><Citation>Rattka M, Dreyhaupt J, Winsauer C, et al. (2020). Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis. Heart, heartjnl-2020-318360.</Citation><ArticleIdList><ArticleId IdType="pubmed">33334863</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinstadler SJ, Reindl M, Lechner I, et al. (2020). Effect of the COVID-19 pandemic on treatment delays in patients with ST-segment elevation myocardial infarction. J Clin Med, 9 (7):2183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7408681</ArticleId><ArticleId IdType="pubmed">32664309</ArticleId></ArticleIdList></Reference><Reference><Citation>Masroor S. (2020). Collateral damage of COVID-19 pandemic: delayed medical care. J Card Surg, 35 (6):1345–1347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276840</ArticleId><ArticleId IdType="pubmed">32419177</ArticleId></ArticleIdList></Reference><Reference><Citation>Pessoa-Amorim G, Camm CF, Gajendragadkar P, et al. (2020). Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes, 6 (3):210–216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543872</ArticleId><ArticleId IdType="pubmed">32467968</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rosa S, Spaccarotella C, Basso C, et al. (2020). Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J, 41 (22):2083–2088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239145</ArticleId><ArticleId IdType="pubmed">32412631</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia S, Albaghdadi MS, Meraj PM, et al. (2020). Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol, 75 (22):2871–2872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151384</ArticleId><ArticleId IdType="pubmed">32283124</ArticleId></ArticleIdList></Reference><Reference><Citation>Roffi M, Guagliumi G, Ibanez B. (2020). The obstacle course of reperfusion for ST-segment–elevation myocardial infarction in the COVID-19 pandemic. Circulation, 141 (24):1951–1953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7294591</ArticleId><ArticleId IdType="pubmed">32315205</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D, Adamo M, Italia L, et al. (2020). Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown), 21 (11):874–881.</Citation><ArticleIdList><ArticleId IdType="pubmed">32941325</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamarullah W, Sabrina AP, Rocky MA, Gozali DR. (2021). Investigating the implications of COVID-19 outbreak on systems of care and outcomes of STEMI patients: A systematic review and meta-analysis. Indian Heart J, 73 (4):404–412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257902</ArticleId><ArticleId IdType="pubmed">34474750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Xing W, Wang H, Song J, Sun Z, Li X. (2021). Characteristics of patients with ST-segment elevated myocardial infarction (STEMI) at the initial stage of the COVID-19 pandemic: a systematic review and meta-analysis. Infect Dis (Lond), 53 (11):865–875.</Citation><ArticleIdList><ArticleId IdType="pubmed">34311652</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew NW, Ow ZGW, Teo VXY, et al. (2021). The global Effect of the COVID-19 pandemic on STEMI care: a systematic review and meta-analysis. Can J Cardiol, 37 (9):1450–1459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056787</ArticleId><ArticleId IdType="pubmed">33848599</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev, 10 (1):89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, et al. (2018). Fourth Universal Definition of Myocardial Infarction (2018). Circulation, 138 (20):e618–e651.</Citation><ArticleIdList><ArticleId IdType="pubmed">30571511</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo CY, Bonsu KO, Nallamothu BK, et al. (2018). Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis. Heart, 104 (16):1362–1369.</Citation><ArticleIdList><ArticleId IdType="pubmed">29437704</ArticleId></ArticleIdList></Reference><Reference><Citation>Farahnak A, Mobedi I, Massoud J, Baharsefat M, Rokni M. (2007). Seroepidemiology of Human Hydatidosis in Golestan Province, Iran. Iran J Parasitol, 2(2):20–24.</Citation></Reference><Reference><Citation>Balduzzi S, Rücker G, Schwarzer G. (2019). How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health, 22 (4):153–160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S, Robins JM. (1985). Estimation of a common effect parameter from sparse follow-up data. Biometrics, 41 (1):55–68.</Citation><ArticleIdList><ArticleId IdType="pubmed">4005387</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins J, Breslow N, Greenland S. (1986). Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models. Biometrics, 42 (2):311–23.</Citation><ArticleIdList><ArticleId IdType="pubmed">3741973</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath S, Zhao X, Steele R, Thombs BD, Benedetti A, Collaboration DSD. (2020). Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res, 29 (9):2520–2537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390706</ArticleId><ArticleId IdType="pubmed">32292115</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21 (11):1539–1558.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. (2005). Bias and efficiency of meta-analytic variance estimators in the random-effects model. J Educ Behav Stat, 30 (3):261–293.</Citation></Reference><Reference><Citation>Abdelaziz HK, Abdelrahman A, Nabi A, et al. (2020). Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center. Am Heart J, 226:45–48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211651</ArticleId><ArticleId IdType="pubmed">32497914</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew NW, Sia CH, Wee HL, et al. (2021). Impact of the COVID-19 Pandemic on Door-to-Balloon Time for Primary Percutaneous Coronary Intervention - Results From the Singapore Western STEMI Network. Circ J, 85(2):139–149.</Citation><ArticleIdList><ArticleId IdType="pubmed">33162491</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinier G, Hayiroglu M, Pay L, et al. (2020). Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Turk Kardiyol Dern Ars, 48 (7):640–645.</Citation><ArticleIdList><ArticleId IdType="pubmed">33034585</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca G, Verdoia M, Cercek M, et al. (2020). Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI. J Am Coll Cardiol, 76 (20):2321–2330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834750</ArticleId><ArticleId IdType="pubmed">33183506</ArticleId></ArticleIdList></Reference><Reference><Citation>Erol MK, Kayıkçıoğlu M, Kılıçkap M, Güler A, et al. (2020). Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study. Anatol J Cardiol, 24(5):334–342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7724394</ArticleId><ArticleId IdType="pubmed">33122486</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluckman TJ, Wilson MA, Chiu ST, et al. (2020). Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic. JAMA Cardiol, 5 (12): 1419–1424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414426</ArticleId><ArticleId IdType="pubmed">32766756</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannan EL, Wu Y, Cozzens K, et al. (2021). Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York. Am J Cardiol, 142:25–34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723434</ArticleId><ArticleId IdType="pubmed">33301770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobo O, Efraim R, Saada M, et al. (2020). The impact of lockdown enforcement during the SARSCoV-2 pandemic on the timing of presentation and early outcomes of patients with ST-elevation myocardial infarction. PLoS One, 15(10):e0241149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584161</ArticleId><ArticleId IdType="pubmed">33095801</ArticleId></ArticleIdList></Reference><Reference><Citation>Little CD, Kotecha T, Candilio L, et al. (2020). COVID-19 pandemic and STEMI: pathway activation and outcomes from the pan-London heart attack group. Open Heart, 7 (2):e001432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592245</ArticleId><ArticleId IdType="pubmed">33106441</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengal N, Saghir T, Rizvi SNH, et al. (2020). Acute ST-Elevation Myocardial Infarction Before and During the COVID-19 Pandemic: What is the Clinically Significant Difference? Cureus, 12 (9): e10523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574816</ArticleId><ArticleId IdType="pubmed">33094064</ArticleId></ArticleIdList></Reference><Reference><Citation>Nan J, Meng S, Hu H, et al. (2020). Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020. Med Sci Monit, 26:e927061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521072</ArticleId><ArticleId IdType="pubmed">32938901</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C, Liu S, Yin D, et al. (2021). Impact of public health emergency response to COVID-19 on management and outcome for STEMI patients in Beijing—a Single-Center Historic Control Study. Curr Probl Cardiol, 46 (3):100693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462598</ArticleId><ArticleId IdType="pubmed">33032817</ArticleId></ArticleIdList></Reference><Reference><Citation>Primessnig U, Pieske BM, Sherif M. (2021). Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemic. ESC Heart Fail, 8 (1):333–343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7835606</ArticleId><ArticleId IdType="pubmed">33283476</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam CCF, Cheung KS, Lam S, et al. (2020). Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment–elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes, 13 (4):e006631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147280</ArticleId><ArticleId IdType="pubmed">32182131</ArticleId></ArticleIdList></Reference><Reference><Citation>Gramegna M, Baldetti L, Beneduce A, et al. (2020). ST-Segment–Elevation myocardial infarction during COVID-19 pandemic: insights from a regional public service healthcare hub. Circ Cardiovasc Interv, 13 (8):e009413.</Citation><ArticleIdList><ArticleId IdType="pubmed">32791953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson SJ, Connolly MJ, Elghamry Z, et al. (2020). Effect of the COVID-19 pandemic on ST-segment–elevation myocardial infarction presentations and in-hospital outcomes. Circ Cardiovasc Interv, 13 (7):e009438.</Citation><ArticleIdList><ArticleId IdType="pubmed">32600109</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong JC, Schwartz KL, Campitelli MA, et al. (2018). Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med, 378 (4):345–353.</Citation><ArticleIdList><ArticleId IdType="pubmed">29365305</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinson L, Mutter R, Viboud C, et al. (2013). Impact of the fall 2009 influenza A (H1N1) pdm09 pandemic on US hospitals. Med Care, 51 (3):259–65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6669026</ArticleId><ArticleId IdType="pubmed">23295577</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon MD, McNulty EJ, Rana JS, et al. (2020). The Covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med, 383 (7):691–693.</Citation><ArticleIdList><ArticleId IdType="pubmed">32427432</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesnier J, Cottin Y, Coste P, et al. (2020). Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study. Lancet Public Health, 5 (10):e536–e542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7498416</ArticleId><ArticleId IdType="pubmed">32950075</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A. (2020). Ambulance waiting times soared in March as calls hit record high. Health Serv J.</Citation></Reference><Reference><Citation>Oettinger V, Stachon P, Hilgendorf I, et al. (2022). COVID-19 pandemic affects STEMI numbers and in-hospital mortality: results of a nationwide analysis in Germany. Clin Res Cardiol, 112(4):550–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9534737</ArticleId><ArticleId IdType="pubmed">36198827</ArticleId></ArticleIdList></Reference><Reference><Citation>Altobelli E, Angeletti PM, Marzi F, D’Ascenzo F, Petrocelli R, Patti G. (2022). Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis. J Clin Med, 11 (9):2323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9102296</ArticleId><ArticleId IdType="pubmed">35566450</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew NW, Sia CH, Wee HL, et al. (2021). Impact of the COVID-19 pandemic on door-to-balloon time for primary percutaneous coronary intervention—results from the Singapore western STEMI Network—. Circ J, 85 (2):139–149.</Citation><ArticleIdList><ArticleId IdType="pubmed">33162491</ArticleId></ArticleIdList></Reference><Reference><Citation>Jneid H, Addison D, Bhatt DL, et al. (2017). 2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non–ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol, 70 (16):2048–2090.</Citation><ArticleIdList><ArticleId IdType="pubmed">28943066</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y. (2020). A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience. Eur Heart J, 41(23):2148–2149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197579</ArticleId><ArticleId IdType="pubmed">32338764</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T, Huang Y, Li W, et al. (2021). The number of patients with acute myocardial infarction decreased and door-to-balloon time delayed in COVID-19. Cardiol Res Pract, 2021: 6673313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7996045</ArticleId><ArticleId IdType="pubmed">33791126</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoulah A, Hersi AS, Al-Faifi SM, et al. (2021). STEMI and COVID-19 Pandemic in Saudi Arabia. Curr Probl Cardiol, 46 (3):100656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7374127</ArticleId><ArticleId IdType="pubmed">32839042</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammalleri V, Muscoli S, Benedetto D, et al. (2020). Who Has Seen Patients With ST-Segment–Elevation Myocardial Infarction? First Results From Italian Real-World Coronavirus Disease 2019. J Am Heart Assoc, 9 (19):e017126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7792389</ArticleId><ArticleId IdType="pubmed">32901560</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>